A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults

Clinical trial NCT06998004 · COMPLETED

Trial details

NCT number: NCT06998004
Sponsor: AstriVax Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Yellow Fever Rabies

Start date: 2024-06-16
Primary completion: 2026-01-26
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.